Kenneth J. Zuerblis is on the board of Resverlogix Corp., Stemline Therapeutics, Inc. and Zenith Capital Corp. (Alberta).

In his past career he occupied the position of Chief Financial Officer of Enzon Pharmaceuticals, Inc., Chief Financial Officer, Treasurer & Executive VP for Savient Pharmaceuticals, Inc., Chief Financial Officer & Senior Vice President at ImClone LLC and Controller for KPMG LLP.

He received an undergraduate degree from Seton Hall University.